German oncology clinics are working with Optima Pharma to create an automated manufacturing unit for decentralised production of CAR T-cell therapies in treatment centres.
Optima Pharma and Optima Life Science in alliance with COMEDCO offers a development and technology partnership for customers that will help them bring TDS and ODF products to market quickly and in a targeted manner